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A major challenge in nanomedicine is the preparation of nano-tools with the ability to 
selectively targeting diseased tissues. Functionalization of nanoparticles (NPs) by 
conjugation with specific ligands possessing the inherent ability to bind only cell subsets 
confer “smartness” to NPs. Due to their small sizes, nanostructures exhibit unique 
physicochemical and biological properties, such as enhanced reactive area  and the ability 
to cross tissue barriers, making them a favorable material for biomedical applications. 
NPs vary in size ranging from 5 to 500 nm. Through the manipulation of size, surface 
chemistry and material structure, NPs can be tailored to carry therapeutic or imaging 
agents for delivery to specific tissues. In particular, surface functionalization can modify 
NP interaction with the immune system cells and the acquisition of stealth or specific-
targeting properties. NP surface decoration with peptide moieties is one of the most 
efficacious cell-targeting strategies. In the first part of my PhD project, I focused on NP 
surface functionalization with stable proteins that interact with different immune cells in 
a selective manner. I used chemokines (chemo-attractant cyto-kines) due to their role in 
physiological and pathological binding and regulation of immune cells, as well as their 
structural stability in biological media. I modified a prototype SiO2-NP surface with the 
chemokine CXCL5, adsorbed or covalently bound, to precisely targeting CXCR2+ 
immune cells. The development of CXCL5-NPs and the discovery of their targeting 
properties provide novel results. Specifically, these protein-decorated nano-tools showed 
enhanced uptake and precise receptor-mediated cell subset localization.  Moreover, given 
the crucial role of CXCR2 in inflammatory responses and cancer biology, CXCL5-NPs 
pave the way to prepare new delivery systems with increased capabilities and potential 
modulation of immune responses. 
In the second part of my PhD project, I evaluated the effects of PtNPs on HL60 (Human 
promyelocytic leukemia cells) and differentiated HL60 (Neutophils-like cells) cells in 
immune responses and inflammatory diseases. Reactive Oxygen Species (ROS) 
removing activity within cells is often achieved with different catalytic nanomaterials. 
Among them, PtNPs attract great attention due to their efficient catalysis and good degree 
of cyto-compatibility, but information about their effects on the human immune system 
is still missing. Further investigation using undifferentiated and differentiated neutrophil-
like HL60 confirmed the harmlessness and non-cytotoxicity of PtNPs with non-adherent 
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innate immune cells, contributing to the knowledge of PtNP interaction with immune 
cells in view of their potential applications in nanomedicine. 
 Chemokine mediated selective targeting of nanoparticles 
1. Introduction 
1.1 Nanoparticles definition and characteristics 
NPs are solid, colloidal particles with size range from 10 nm to <1000 nm [1]. Due to 
their small size and large surface area, NPs are used to increase drug solubility and 
enhanced bioavailability. Depending on physical-chemical characteristics some of them 
have the ability to cross  the blood brain barrier (BBB), enter the pulmonary system and 
be absorbed through the tight junctions of endothelial cells of the skin [2]. In particular 
NPs made from natural and synthetic biodegradable polymers have received more 
attention because polymers undergo hydrolysis in the body, producing biodegradable 
metabolite monomers, such as lactic acid and glycolic acid [3]. NPs can be released 
through direct injection, inhalation and oral intake. Once, they enter systemic circulation, 
particle-protein interaction happens immediately before their distribution into the various 
organs. Shape, size and surface chemistry of NPs affects how cells ‘‘see” them and dictate 
their distribution, toxicity, and targeting ability. To create efficient nano-drug delivery 
systems, the functionalization with targeting ligands, surface curvature and reactivity are 
crucial features to consider, in order to avoid NP aggregation, improving their stability 
and guarantee the pharmacological effects of the drug [4]. The more hydrophobic NPs 
are, the more likely will be cleared because of the higher binding affinity to blood 
components [5]. As hydrophobic NPs are cleared easily, making their surface hydrophilic 
would increase their time in circulation. In particular polyethylene glycol (PEG) is a 
hydrophilic and relatively inert polymer that when linked onto the NP surface, hinders 
the binding of plasma avoiding phagocytosis of the particle by tissue macrophages 
(opsonization), preventing the particles degradation. PEGylated NPs are considered as 
‘‘stealth” NPs, because they escape the surveillance of reticuloendothelial system (RES) 
better than other NPs [6]. RES consists of cells descending from monocytes which are 
able to perform phagocytosis of foreign materials and particles. The most important 
function of the RES is phagocytosis, but it also takes part in cytotoxicity against tumor 
cells and has a function in the regulation of the immune system [7]. RES is able to 
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recognize the circulating nanoparticles, causing a major loss of the injected dose (>50%) 
within a few hours after intra venous injection. Theoretically, a perfectly stealth NP 
should not be opsonized at all and should stay in the circulation until it encounters and 





Representation of opsonization process by macrophages. Opsonins are unable to bind 
nanoparticles coated with polymers that don’t undergo phagocytosis [8]. 
 
1.2 Classification of different types of nanoparticles   
According to the different characteristics and functionality of the materials, NPs could be 
divided in different classes. The most important are inorganic, organic and carbon based 
NPs [9]. 
1.2.1 Inorganic nanoparticles. 
Inorganic NPs are particles that are not made up of carbon. Metal and metal oxide based 
nanoparticles are the most important classes. Some of inorganic NPs have optical, 
electronic, magnetic and catalytic properties. The most used NPs are iron oxides, gold, 
silver, quantum dots, silica and carbon-based [10].  
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 Metal based Nanoparticles. They are synthesized from metals to nanometric 
sizes and the commonly used metals for nanoparticle synthesis are aluminum, 
cadmium, cobalt, copper, gold, iron, lead, silver and zinc. NPs have distinctive 
properties such sizes as low as 10 to 100 nm, high surface area to volume ratio, 
pore size, surface charge and surface charge density, crystalline and 
amorphous structures, shapes like spherical and cylindrical [11].They have 
been used in different medical applications, such as bioimaging, biosensor, 
hyperthermia, sustained drug deliver [12][13].   
 
 Metal oxides based. The metal oxide based NPs are synthesized to modify 
the properties of their respective metal based NPs, for example NPs of iron 
instantly oxidizes to iron oxide  in the presence of oxygen at room temperature 
that increases its reactivity compared to iron NPs. The commonly synthesized 
are Aluminum oxide, Cerium oxide, Iron oxide, Silicon dioxide, Titanium 
oxide, Zinc oxide [14]. 
 
 Silica nanoparticles. Silica NPs (SiO2) have obtained great interest to be used 
for biomedical applications and they can be categorized as mesoporous or 
non-porous (solid) NPs. Mesoporous SiO2 NPs are characterized by the 
mesopores (2-50 nm pore size) and are used for delivery of pharmacological 
compounds based on physical or chemical adsorption [15][16]. They are also 
promising candidates for improved drug delivery systems. Drug molecules 
have been loaded into SiO2 NPs and surface modification of the NPs with bio 
recognition entities can allow specific cells or receptors in the body to be 
located [17]. There are various methods of  NPs preparation such as Stöber 
method, reverse micro emulsion, sol-gel method, spray drying, template 
method, heating degradation etc. [18][19]. The synthesis of mesoporous silica 
is accomplished using sol–gel chemistry in the presence of surfactants. 
Furthermore, thermal crosslinking rigidifies the preceramic material, and then, 
the surfactant is removed to expose the pore structure [20]. SiO2 NPs can be 
used for stimuli-responsive drug delivery, photodynamic therapy, gene 






NPs made completely of carbon are knows as carbon based. They can be classified into 
fullerenes, graphene, carbon nanotubes (CNT), carbon nanofibers and carbon black 
 Fullerenes. Fullerenes is a carbon molecule that is spherical in shape and 
made up of carbon atoms held together by sp2 hybridization. About 28 to 1500 
carbon atoms forms the spherical structure with diameters up to 8.2 nm for a 
single layer and 4 to 36 nm for multi-layered fullerenes. 
 Graphene. Graphene is an allotrope of carbon and it is a hexagonal network 
of honeycomb lattice made up of carbon atoms in a two dimensional planar 
surface. Generally the thickness of the graphene sheet is around 1 nm [14]. 
 Nanotubes are self-assembling sheets of atoms arranged in tubes with single- 
or multiwalled structures, with large internal volume. The external surface of 
nanotubes can be easily functionalized [21]. One of the most popular 
nanotubes is CNT. They are graphene sheets rolled up into tubular form, 
wherein each layer consists of hexagonal networks of carbon atoms. 
Nanotubes are divided in single-walled nanotubes (SWNTs) and multi-walled 
nanotubes layers of graphite characterized by a large surface area and an 
excellent electronic and thermal conductivity [22]. Boron nitride nanotube 
(BNNT) has similar tubular nanostructure as carbon nanotube (CNT) in which 
boron and nitrogen atoms arranged in a hexagonal network. Owing to the 
unique atomic structure, BNNT has numerous excellent intrinsic properties 
such as superior mechanical strength , high thermal conductivity, electrically 
insulating behavior, piezoelectric property, neutron shielding capability, and 
oxidation resistance [23]. 
 Carbon Nanofiber. The same graphene nanofoils are used to produce carbon 
nanofiber as CNT but wound into a cone or cup shape instead of a regular 
cylindrical tubes. 
 Carbon black. An amorphous material made up of carbon, generally 
spherical in shape with diameters from 20 to 70 nm. The interaction between 
the particles are so high that they bound in aggregates and around 500 nm 





Usually a nanocrystals have a size smaller than 100 nm and they are aggregates of around 
hundreds or thousands of molecules that combine in a crystalline form, composed of drug 
surrounded by a thin coating comprised of surfactant [22]. There is no carrier material in 
nanocrystals and are composed of 100% of drug [24]. The traditional method involves 
molecular precursors, which can include typical metal salts and a source of the anion like 
chalcogenides (SS−, SeS−, TeS−) and pnictides (P3−, As3−, Sb3−).  
 
Quantum dots  
Quantum dots (QDs) are known as semiconductor nanocrystals with diameter range from 
2 to 10 nm and their optical properties, such as absorbance and photoluminescence are 
size-dependent [25]. QDs have obtained great attention in the field of nanomedicine 
because they presents emission in the near-infrared region (< 650 nm), a very desirable 
characteristic in the field of biomedical images, due to the low absorption by the tissues. 
In this sense, QDs are very appealing for multiplex imaging, as targeted drug delivery, 
sensors and bioimaging [22]. 
 
Magnetic nanoparticles 
Magnetic NPs can be composed of cobalt, nickel, manganese, and iron and exhibit a wide 
variety of properties which make them highly promising carriers for drug delivery. In 
particular, with the aid of an external magnetic field  they could be used for passive and 
active drug delivery strategies [26]. 
1.2.2 Organic nanoparticles 
Organic NPs can be explained as solid particles composed of organic compounds (mainly 
lipids or polymeric) ranging in diameter from 10 nm to 1 µm. Most important classes are 
dendrimers, micelles and liposomes. Organic NPs usually are biodegradable and non- 
toxic. They can load molecules either by conjugation on the surface or in the core, or by 
physical encapsulation, which makes them appealing systems for drug delivery and 




 Liposome. They are vesicles of spherical form composed of phospholipids 
and steroids, their membrane structure is similar to the cell membranes and 
they are also biocompatible and biodegradable [27][22]. Liposomes reveal 
several exclusive properties such as long systemic circulation half-life, 
surface modifications and safety profiles for both hydrophilic and lipophilic 
drugs. Most of the liposomes are  PEG coated because PEGylated liposomes 
decrease the monocyte system uptake, increase circulation time and reduce 
immune recognition [28]. These kinds of liposomes are called stealth 
liposome or sterically stabilized liposomes [29]. Liposomes have been used 
to improve the therapeutic index of new or established drugs by modifying 
drug absorption, reducing metabolism, prolonging biological half-life or 
reducing toxicity. Lipids forming liposomes may be natural or synthetic, and 
liposome constituents are not exclusive of lipids, new generation liposomes 
can also be formed from polymers (sometimes referred to as polymersomes) 
[29]. Liposomes used for gene delivery into cells are called genosomes. For 
the production of genosomes, cationic phospholipids were found to be more 
suitable because they possess high biodegradability and stability in the blood 
stream [29]. 
 Polymeric nanoparticles. Polymeric NPs are colloidal particles of size range 
10 nm–1 μm and solid in nature. They include conjugates, dendrimers, 
micelles, nanoparticles, nanogels and polymerosomes. Depending on 
preparation method, polymeric nanoparticles can form two types of 
structures: nanosphere and nanocapsule. Nanospheres consist of matrix 
system in which the drug is uniformly dispersed whereas in nanocapsules the 
drug is embedded in a cavity and the cavity is surrounded by a polymeric 
membrane. Polymeric nanoparticles have immense potential as drug carriers 
as they can deliver drugs in various organ systems. They can be made from 
synthetic and natural polymers. The most widely used synthetic polymers are 
polylactide, polylactide–polyglycolide copolymers, polycaprolactones, and 
polyacrylates. Among the various natural polymers, alginate, albumin, or 
chitosan have been widely explored [30]. Alginate (ALG) is a water soluble 
linear polysaccharide extracted from brown sea weed and is composed of 
alternating blocks of 1-4 linked α-L-guluronic and β-Dmannuronic acid 
residues. ALG has been reported to be muco-adhesive, biodegradable, and 
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biocompatible [31][32]. Alginate micro and nanoparticles can be obtained 
easily by inducing gelation with calcium ions [33][34]. Chitosan (CS) a linear 
polysaccharide consisting of glucosamine and N-acetylglucosamine units, is 
biocompatible, biodegradable, and nontoxic. The addition of CS can not only 
endow nanoparticles positive surface charge, but also prolong the time that 
the active ingredients contact with the epithelium and enhance absorption via 
the para-cellular transport pathway through the tight junctions [35][36]. 
Synthetic polymers undergo hydrolysis in the body, producing biodegradable 
monomers. The drug can be entrapped or encapsulated within the carrier, 
physically adsorbed on the surface of the carrier, or chemically linked to the 
surface. These nanocarriers are known by their attractive characteristics, such 
as small size, biodegradability, water solubility, nontoxicity, long shelf life, 
and stability during storage. These characteristics make them a point of 
interest for the delivery of drugs, proteins, and DNA or genes to specific 
targeted tissues or organs [37]. 
 Dendrimers. Dendrimers are nano-sized, radially symmetric molecules with 
well-defined, homogeneous and monodisperse structure consisting of tree-
like arms or branches. Manipulating these structural features of dendrimers 
allows controlled synthesis of a whole series of highly branched end-
functionalized macromolecules that are drawing increased attention for many 
potential applications [38]. They could be made of globular, monodisperse, 
three dimensional nanoscales synthetic polymers [22]. The drug may be 
encapsulated in the internal structure of dendrimers or it can be chemically 
attached or physically adsorbed on dendrimers surface. Usually encapsulation 
is used for toxic or poorly soluble drugs. Instead covalent coupling provides 














Examples of NPs that could be used as carriers for drug delivery and selective 
targeting. Representation of different types of organic and inorganic NPs [40]. 
 
1.3 Nanoparticles for targeting pathological tissues. 
One major challenge in nanomedicine is to create a nano-tool that can selectively target 
diseased tissues. The penetration of NPs in tissues can occur passively or actively. Active 
targeting occurs when the drug carrier system is conjugated to a cell-specific ligand or 
absorbed on NPs surface. The passive targeting is achieved by incorporating the 
therapeutic agent into a NP that reaches the target organ without modification of its 
surface. In this strategy, the leaky nature of vessels in cancer tissue and lack of well-
defined lymphatic system can enhance the permeation and retention of NPs, which is 









Schematic representation of passive (A) and active (B) targeting. Examples of 
different molecules involved in active and passive targeting [42]. 
 
An ideal drug delivery system should be able to bind and deliver its load to specific 
pathologic tissues, and minimize or avoids drug-induced collateral damage to the healthy 
tissues. Coating the NP surface with specific ligands is a fruitful strategy. These ligands 
could be small molecules, peptides, antibodies, designed proteins, nucleic acid and 
aptamers [43]. Commonly used ligands are Biotin (vitamin H), due to its very high 
affinity for streptavidin, and folic acid (vitamin B9), because of its binding for 
endogenous folate receptor that is, for example, overexpressed in many types of cancers 
[44]. The most common peptide used for targeting is RGD that binds integrins on the cell 
surface involved in cell migration, growth, differentiation and apoptosis in addition to 
cell–cell integrations. Integrin αvβ3 that bind to RGD peptides with high affinity is 
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involved in intracellular signaling and direct roles in tumor angiogenesis. Recent uses of 
RGD peptides for treating cancer include conjugation of PEGylated RGD peptides to gold 
nanoshells that are able to target U87 glioblastoma cells [45]. Carbohydrates, which 
interact weakly with some cell surface receptors, can also serve as NPs small molecule 
targeting ligands. In particular, carbohydrates permit NPs glyco-targeting, which is based 
on endogenous lectin interactions with carbohydrates. A disadvantage of this targeting 
method is that glycol-targeting often requires multiple interacting carbohydrates to 
achieve strong enough binding strength [43]. Moreover, AuNPs with diameter ≤ 50 nm 
can cross the BBB (ref). Gold nanorod–DARPP–32 siRNA complexes have been 
developed to target and diminish expression of the key proteins (DARPP-32), 
extracellular signal-regulated kinase (ERK), and protein phosphatase 1 (PP-1) in the brain 
cell dopaminergic signaling pathway for ailment of drug addiction [46]. Magnetic NPs 
are able to target a specific site in the human body due to applied magnetic field. Usually 
these particles contain magnetic cores encapsulated by polymer or metal coating, or may 
consist of porous polymers containing magnetic NP precipitate within the pores [47].  
Recently a group of researchers used therapeutic ceria (CeO2) NPs to remove ROS in 
mice genetically modified to show the symptoms of Alzheimer disease. CeCO2 NPs 
worked as strong and recyclable ROS scavengers shuttling between Ce 3+ and Ce4+  
oxidation states [48]. Recently, Aouadi et al. investigated the efficacy of β-glucan-
encapsulated siRNA particles as oral delivery vehicles to targeting macrophages. These 
NPs can silence the Map4k4 gene and protect animals from lipopolysaccharide-induced 
lethality [49]. Aptamer-conjugated nanoparticles have immense application including 
early diagnosis and drug delivery. For instance, the 20-fluorinated A10 RNA aptamer-
conjugated on Poly(lactic-co-glycolic acid)-polyethylene glycol (PLGA-PEG) NPs shall 
be adopted in targeted prostate-specific membrane antigen in case of prostate cancer 
model [50]. 
 
1.4 Covalent coupling 
Significant research effort has been devoted to decorating NP surfaces with a range of 
biological moieties to target specific cellular receptors, using a range of methods 
including adsorption, covalent coupling and specific interactions, resulting in biologically 
active composite NPs [51]. Covalent conjugation is attractive as it can provide a route to  
irreversibly bound biofunctional layer, which would be expected to be stable across the 
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biological conditions. The most common procedures utilize carbodiimide chemistry, 
whereby the amine of the biomolecule forms an amide bond to a carboxylated 
nanoparticle. This so-called “EDAC” chemistry is a biocompatible coupling procedure 
which can be performed in one step with 1-etil-3-(3 dimethylaminopropil) carbodiimide 
(EDAC) forming an active intermediate with carboxylic acids susceptible to amine 
substitution. This chemistry has been applied to functionalization of a range of 
nanoparticle types including silica [52] polystyrene [53] and gold [54]. N-
hydroxysuccinimide or sulfo-N-hydroxysuccinimide can also be used in parallel to form 
an activated ester and avoid NPs aggregation. For amino functionalized particles a 
common functionalization approach is to use the bifunctional glutaraldehyde as a cross-
linking agent between the particle and protein amino groups with the formation of a  
reversible imine groups. This method has been commonly applied to the amino 






Representation of EDC–NHS chemistry: EDC reacts with a carboxylic-acid group, 
forming an amine-reactive O-acyl isourea intermediate. This intermediate may reacts 
with an amine, yielding a conjugate of the two molecules joined by a stable amide bond. 
The addition of sulfo-NHS stabilizes the amine-reactive intermediate by converting it to 
an amine reactive sulfo-NHS ester, thus increasing the efficiency of EDC-mediated 
coupling reactions [55]. 
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Nevertheless, the direct attachment of a protein to a surface without a spacer can cause 
steric constraint modifying the protein reactivity compared to the protein in solution. In 
addition, without a spacer, multiple contacts between protein and nanoparticle surface are 
more probable favoring total or partial protein denaturation and thus decreasing protein 
activity. The Huisgen cycloaddition “Click” reaction is considered especially attractive 
given its chemoselectivity and stability [56][57].  Gold readily forms Au\S and Au\N 
bonds, thus gold NPs have been used for direct coupling of proteins on their surface 
through binding with free amino and cysteine presenting residues which may be present 
on the targeting moiety. Adsorption effects due to physical interaction between bio-
macromolecule and a range of materials are known to cause significant structural changes 
[58]. For example NPs surface have been shown to induce size dependent effects on 
protein conformation upon adsorption [59][60]. Besides size, as one would expect, 
hydrophobicity and electrostatics play important roles which may be controlled through 
surface chemistry modifications [61][62]. Interestingly in some cases NP conjugation has 
been cited as beneficial to protein activity and stability. Besides the physical effects on 
the protein structure that may result from binding to NP surfaces, the actual directionality 
of the protein components becomes vital as regards biological efficacy because it is 
necessary to ensure the correct epitope presentation in order to engage with the target 
receptor. Greater control of the protein orientation at the NP surface can be accomplished 
through careful attention to surface topography and chemistry properties on one hand, 
and protein structural details on the other. Controlled directionality can be attained 
through advanced protein modification/synthesis techniques to control the point of 
attachment and the consequent interface biological activity. So covalently conjugating 













Several coating agents or ligands for NPs surface functionalization. Representation 
of different molecules used as ligand for selective targeting [63]. 
 
1.5 The role of protein corona 
An evolution from a loosely bound to irreversibly attached protein “corona” around the 
NPs over time has been observed in cell culture media containing serum, a process that 
potentially correlates the cellular uptake and other biological processes with NP-protein 
complexes. Numerous NMs show the intrinsic property to adsorb specific proteins present 
in biological fluids that can be used as targeting molecule to drive cell localization [64]. 
Although the formation of a selective protein corona is attractive it cannot exclude some 
concerns regarding the non-advantageous peptide orientation or the presence of 
conformational changes due to the chemical and physical interactions with the particle 
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surface [65]. In particular, drug delivery systems often require the release of NPs into the 
bloodstream, which is populated by blood cells and small peptides, proteins, sugars, 
lipids, and complexes of all these molecules. Generally, in biological fluids, a NPs surface 
is covered by different biomolecules, which influence their interactions with tissues and 
cells. The adsorption of molecules onto the nanomaterial is defined as “corona” 
formation. Every blood particulate component, in particular proteins and extracellular 
matrix components can contribute to the creation of the corona. Many different physical 
events contribute to a corona’s formation, such as temperature, pH, and the time of 
interaction between the NPs and the medium’s components. The protein corona can be 
distinguished in “hard corona” and “soft corona” [66]. The hard corona contains proteins 
with a higher affinity for the NP surface that may irreversibly bind the chemical moieties 
on the particle. In contrast, the soft corona layer harbors proteins that have a lower affinity 






Schematic illustration and characteristics of a hard and a soft corona [67]. 
 
Hard coronas are characterized by slow exchange (ie, several hours) and lower 
abundance, with a high affinity of proteins, whereas soft coronas are characterized by 
rapid exchange (ie, several minutes) and lower affinity of proteins with weakly bound 
outer layers on NPs [67]. Many of these proteins increase NP internalization into cells by 
specific binding with their cognate receptors expressed on cell membranes, whereas 
others are reported to avoid NP internalization, such as CD47 or clusterin [68][69]. These 
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observations have encouraged some researchers to use this strategy to evaluate the effect 
protein corona for NP surface functionalization aimed at type-specific cell delivery [64]. 
Protein denaturation, steric hindrance (crowding), an unfavorable orientation due to the 
rearrangement of their spatial configurations to adapt to the NM could influence the fate 
and the functionality of NPs in cellular uptake [70]. Changes in protein conformation may 
create new epitopes towards the cellular interaction leading to inappropriate signaling. 
On the contrary, proteins could not modify their tertiary structure if the NM has high 





Overview of NM-protein interaction: cause and effect of nanobiointerface. Protein 
adsorption on NMs depends on physiochemical properties of NMs, such as size, shape, 
and charges on the NMs surface. Proteins often are affected by conformational changes 
upon NM interaction. The secondary structure (𝛼-helices, 𝛽-sheets, and random coils) 
gets perturbed due to interaction with NMs. The binding of proteins onto NMs can lead 








Reversible and irreversible changes of protein by NP interaction. Minute structural 
changes of protein by NPs, which would be regained by removal of NPs, can be 
considered as reversible mechanism. Significant NP-induced changes of protein structure 
(loss of 𝛽-sheets, 𝛼-helix), which will never be restored by removing NPs, may produce 
irreversible changes [71]. 
Tonigold et al. demonstrated that the pre-adsorption of antibodies against the CD63 
antigen of monocyte-derived dendritic cells or the T lymphocyte CD3 antigen exerts 
remarkable targeting properties, proving that pre-coating with particular antibodies could 
be a promising approach to targeted NP-mediated delivery [72]. The precise detection of 
structural modifications occurring in adsorbed proteins is very challenging and requires 
the coordinated employment of several techniques, including Dynamic Light Scattering 
(DLS), electron microscopy, electrophoresis, Circular Dichroism (CD), Fourier 
Transform Infrared Spectroscopy (FTIR), Mass Spectroscopy (MS), and Nuclear 
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Magnetic Resonance (NMR) [73]. The ratio between NP and protein size is an important 
factor determining the amount of adsorbed proteins and alterations in their structure. It is 
realistic to presume that if the NP is much bigger than a single protein, more peptides can 
be harbored on the NP surface. On the other hand, smaller NPs of the same material have 
less contact with protein domains and a lower chance to induce structural changes. In 
agreement with this hypothesis, 110 nm citrate and Polyvinylpyrrolidone (PVP)-
stabilized Ag NPs were found to bind a higher number of proteins compared to 20 nm 
citrate and PVP-stabilized Ag NPs, suggesting a different corona formation due to size 
and surface curvature of the NPs [74]. Actually, it has been shown that the adsorption of 
certain proteins on 100 nm NPs induces increased protein modification compared to 
particles of the same material smaller than 5 nm. In addition, the surface charge and 
hydrophilicity of NPs can affect proteins conformation. In particular, neutral part of 
protein does not attach to the NPs surface whereas charged portion majorly affect their 
orientation and folding on the surface of NPs [70]. Studies on polystyrene NPs 
demonstrated that proteins with an isoelectric point of less than 5.5 (e.g., albumin) mainly 
adsorbed on positively charged particles, whereas proteins with higher values (e.g., IgG) 
prefer negatively charged NPs. Therefore, NP functionalization with negative (e.g., 
COOH) or positive (e.g., NH2) chemical groups may represent a way to select the protein 
coating. Hydrophilic NPs induce very less structural changes to proteins, in contrast to 
hydrophobic NPs. According to Keselowsky et al. [75], attachment of fibronectin on NPs 
surface alters its conformation/structure that affect its cell adhesion capability. The 
avoidance of complement-mediated phagocyte sequestration of NPs remains one of the 
major issues in nanotechnology applications to drug delivery [76]. Poly(ethylene glycol) 
(PEG) covering of NM surfaces is a method to delay phagocyte sequestration and allow 
NM presence in the blood circulation by retarding protein adsorption [77]. PEG 
interaction with specific plasma proteins, such as clusterin, has been shown to be an 
essential event to avoid cellular uptake [78]. Some of the presented properties of protein 
corona have been investigated in my PhD project to explore adsorbed-CXCL5 mediated 
targeting efficiency. 
 
1.6 Silica Nanoparticles synthesis  
During my PhD fellowship, I focused my attention on SiO2 NPs synthesis and 
characterization exploiting their application as targeting tool. SiO2 NPs demonstrated a 
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good degree of biocompatibility and they have the ability to enter the cell without 
affecting cell survival [79]. In vitro studies of SiO2 NPs indicate that the particle surface 
area as well as the particle size or shape may play a crucial role in the toxicity of 
nanosilica. The absence of detectable toxic effects in vitro makes SiO2 NPs a promising 
material for biomedical applications [79]. The sol-gel process is widely used to produce 
silica particles due to its ability to control the particle size, size distribution and 
morphology monitoring the reaction parameters. The process involves hydrolysis and 
condensation of metal alkoxides (Si(OR)4) such as tetraethylorthosilicate (TEOS, Si(OC2 
H5 )4 ) or inorganic salts such as sodium silicate (Na2 SiO3) in the presence of mineral 
acid (e.g., HCl) or base (e.g., NH3) as catalyst  [80][81]. The condensation/polymerization 
between the silanol groups or between silanol groups and ethoxy groups creates siloxane 
bridges (Si–O–Si) that are able to create silica structure. I decided to use the Stöber 
method to produce spheroidal and monodispersed silica NPs by using aqueous alcohol 




Simplified representation of the hydrolysis and condensation of TEOS in the Stöber 





1.7 Chemical Modification of Silica nanoparticles surface  
The chemical modification of silica surface with organo functional groups is an important 
step towards the preparation of silica-polymer nanocomposites. Modification of silica 
surface with silane coupling agents is one of the most effective techniques available. In 
aqueous system, the silanes undergo hydrolysis and condensation before deposition on 
the surface and the alkoxy molecules are hydrolyzed in contact with water. Then, the 
silane molecules are deposited on the silica surface through formation of siloxane bonds 
between the silanol groups and hydrolyzed silanes with the release of water molecules 
[83]. Surface modification of silica nanoparticles can occur by using various types of 
silane coupling agents such as aminopropyltrimethoxysilane and 
methacryloxypropyltriethoxysilane [84]. Surface modification makes possible the 
conjugation of the silica NP surface with polymers or proteins [82]. SiO2 NPs have the 
advantageous ability to encapsulate fluorescent dyes inside their “core”, overcoming 
some limitations presented by free organic dyes, such as high photobleaching rates. 
Fluorescent SiO2 NPs are very useful to study  the interaction between NPs and biological 
system by confocal microscopy, flow cytometry and other optical techniques. Depending 
on the chemical properties of the fluorophore, it is possible to entrap more than one 
fluorophore into the particle [85]. SiO2  NPs negative surface charge can be modified 
either via covalent coupling using silane chemistry, or via physical adsorption and 
electrostatic interactions [86][18]. SiO2 NP surface can be functionalized with different 
molecules, including antibodies, folic acid, aptamers, PEG, carbohydrates, lipids 
[87][88]. Covalent functionalization on the silica surface is possible by using silane 
chemistry. The use of halosilanes and alkoxysilanes allow the introduction of functional 
groups like amines, carboxylates, epoxides and thiols. In my project 3-
aminopropyltrimetoxysilane (APTMS) has been used as coupling agent. APTMS 
promotes strong covalent linkages onto the SiO2 NPs surface creating protonated amine 
groups that allow electrostatic interaction with negatively charged species, such as DNA 
or proteins. Surface functionalization with PEG has been used to modify SiO2 NPs surface 
to enhance the stealth effect of PEG and to avoid the opsonization by macrophages, hiding 
the silanol groups and stabilizing the colloidal particles. Several studies have 
demonstrated that ligand nature affects the interaction with serum proteins and cell 
membrane receptors, and consequently, the pathway by which cells internalize 
nanoparticles determining intracellular localization [89][90]. So the presence of 
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functional ligands (proteins) on NP surface is used to enhance the binding to specific 








Chemokines are small proteins consisting of 70-100 amino acids secreted by almost all 
the cell types. They are chemotactic cytokines able to bind cognate receptors on cell 
membrane. They are involved in the homeostatic movement of cells, as well as leukocyte 
recruitment during immune responses. Some of them can also function as growth and 
angiogenic factor and chemoattractant for cancer cells. Chemokines are characterized by 
the presence of cysteine residues that define four families depending on the number of 
cysteines and the presence or not of amino acids in between them (i.e. CXC, CC, C, and 
CX3C) [93]. They also show a highly conserved tertiary structural fold consisting of 
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three-stranded β-sheet and a α-helix, though their quaternary structures may significantly 
vary with the sub-families [94]. 
1.8.1 CXCL5 
Among the different chemokines that bind the receptor CXCR2 like GROα(CXCL1), 
ENA-78 (CXCL5), and interleukin-8 (IL-8; CXCL8) [95], I have chosen for my project 
the chemokine CXCL5.Structure of CXCL5 also called Epithelial neutrophil- activating 
protein (ENA-78) was initially identified in stimulated epithelial cells A549 since 1990s 
[96]. CXCL5 is composed of a tripeptide motif Glu-Leu-Arg at the NH2 terminus relate 
to neutrophil-activating peptide 2 and growth-related oncogene-a. CXCL5 shares 
structural homological qualities with IL-8 and plays the similar role in processes of 
proliferation, metastasis, angiogenesis and neutrophils infiltration in different types of 
cancers. The monomer structure consists of an extended N-terminal loop (N-loop) 
followed by three β-strands and a terminal α-helix. The core structure is defined by 
hydrophobic contacts between residues of the α-helices and β-strands. CXCL5 is 
considered as a pro-inflammatory and angiogenic factor and it is involved in proliferation, 
invasion, metastasis, angiogenesis in cancer. Targeting CXCL5 may provide therapeutic 




Structure of CXCL5 chemokine. The monomer consists of three antiparallel beta 
strands and an alpha helix; the disulfide bonds are shown in yellow [98]. 
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CXCLs/CXCR2 axis produces multiple signaling pathways, like the PI3K, p38/ERK, and 
JAK involved in cell survival and migration. In particular, extensive infiltration of 
neutrophils during chronic inflammation is one of the most important pathogenic factors 
in various inflammatory diseases. Current therapeutic development of CXCLs/CXCR2 
axis aims at target the receptor, inhibiting CXCR2 ligands through the blockade of 
signaling pathway, by transfecting microRNA (miRNA) in cells and using neutralizing 
antibodies [99]. Based on the knowledge of chemokine ability to bind its cognate receptor 
expressed on immune cells  [100][101][102] as well as  SiO2 NPs cytocompatibility [103] 
[104][79], The starting hypothesis was that the chemokine-receptor binding could 
improve NPs localization on CXCR2 expressing leukocytes. The formulation of NPs 
functionalized with CXCL5 can be considered an innovative tool to prepare precise-






CXCLs/CXCR2 signal transduction pathway. CXCR2 is a typical GPCR. Its 
activation leads to transcription of various genes, such as ERK, p38, AKT, JAK2, and 
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modulates cell survival, angiogenesis, proliferation and senescence. Activation of 
CXCR2 also leads to Ca2+ mobilization Endoplasmic Reticulum and affects cell 
contraction and morphology [99]. 
 
1.9 Chemokine receptors and immune system  
Chemokine and chemokine receptors have an important role in innate immune system. In 
particular, CXCL12/CXCR4 interactions remain essential for bone marrow retention and 
normal development of multiple immune lineages, including B cells, monocytes, 
macrophages, neutrophils, natural killer (NK) cells, and plasmacytoid dendritic cells 
[105]. CXCL14 is homeostatically produced by human fibroblasts in the skin and lamina 
propria, and tissue macrophages can be found in close association with CXCL14-
producing cells [106]. Basophils express CXCR4 and so it is possible that they are 
released into the peripheral blood by CXCR4-mediated mechanisms, where they remain 
in the absence of inflammatory stimuli. Human basophils constitutively express CXCR1, 
CXCR4, CCR1, CCR2, and a majority express CCR3 [107][108]. Mast cells (MCs) are 
found throughout all vascularized tissues, where they act as innate immune sentinels and 
effector cells. Immature, resident DCs express various chemokine receptors (e.g., CCR1, 
CCR2, CCR5, CCR6, CXCR1, CXCR2, and CXCR4) that allow DCs to migrate to sites 
of inflammation, but they may also actively promote their maintenance in the periphery 
[109]. Although resident innate immune cells are the initial responders to inflammatory 
cues, circulating innate cells such as neutrophils, monocytes, and eosinophils quickly 
become the major immune cells during acute inflammation. Neutrophils are cells of acute 
inflammation; they express many chemokine receptors, including CXCR2 and CCR1 in 
mice and CXCR1 and CXCR2 in humans, which respond to early chemokines released 
by MCs and macrophages. Monocytes are defined by their expression of CCR2, they also 
express CXCR2, which may play an important role in initial activation and 
transmigration. In an atheroma model, CXCL8/CXCR2 interactions were necessary for 
firm adhesion of monocytes to vascular endothelium [110]. So, evaluated the important 
role of chemokine receptors in immune system, the use of chemokine to selectively target 









Chemokine control of innate immune cell migration in homeostasis and 




1.10 CXCR2 receptor 
Currently, 19 different chemokine receptors have been discovered, separated into four 
different subfamilies: C, CC, CXC and CX3C. In humans, the CXC subfamily contains 
seven chemokine receptors and 15 ligands. The CXC chemokine subfamily can be 
divided in a group of chemokines containing a glutamic acid leucine- arginine (ELR) 
motif, and a group in which the ELR motif is absent [93][112]. Seven of the 15 CXC 
ligands (CXCL1-3 and CXCL5-8) contain an ELR motif, all having high binding affinity 
for chemokine receptor CXCR2. The receptor belongs to the G coupled protein receptor 
family (GPCR) and it is composed of seven transmembrane segments, three extracellular 
and three intracellular loops, an extracellular N-terminal domain, and a cytosolic C-
terminal segment. The amino acid aspartate in the second extracellular loop and a LLKIL 
motif in the C-terminus are both required for rapid receptor internalization, while the 
second intracellular loop contains a DRY (Asp – Arg – Tyr) motif as the G protein 
docking site, giving the chemokine receptor the ability to signal after ligand binding 
[113]. Chemokine receptors are activated through two-site interaction between the 
chemokine and its receptor. The first step in the receptor binding is the interaction of the 
chemokine’s N terminal residues with the N-terminal domain of the receptor (site 1). 
After receptor activation, the heterotrimeric G protein, Gαβγ, separates into the subunits 
Gα and Gβγ, through the exchange of GDP for GTP on the Gα subunit. The Gβγ subunit 
then activates phospholipase C, which cleaves phosphatidylinositol (4,5)-biphosphate 
into inositol triphosphate and diacylglycerol that promote the rise of intracellular calcium 
causing chemotaxis and degranulation. Among the resulting effects of the chemokine-
receptor binding, internalization of receptor represents the major mechanism for receptor-
recycle and chemokine degradation. Internalization depends on the interactions between 
the chemokine N-terminus and the N-domain of the receptor [114]. In case of the 
recycling pathway, CXCR2 returns back to the cell surface after dephosphorylation, 
while, in the case of the lysosomal sorting pathway, the receptor will be also degraded by 
proteolytic enzymes [115]. The mechanism of receptor internalization is a clathrin-
mediated endocytosis [116]. In particular the process starts with receptor activation by 
the ligand and phosphorylation (mediated by G protein receptor kinases, GRKs) of serine 
or threonine residues near the C-terminus of the receptor, leading to receptor 
desensitization. The phosphorylated receptors favors the recruitment of molecules like 
adaptin 2 and β-arrestin [115].The complex of the receptor with adaptin 2 and β-arrestin  
attracts clathrin, leading to internalization of the receptor from the plasma membrane to 
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form clathrin-coated vesicles. The receptor and the ligand are then transported to 
endosomes in which the chemokine and receptor can dissociate  because of the acidic 
endosomal environment allowing the receptor to be recycled back to the cell membrane 
[115]. Given the crucial role of CXCR2 in inflammatory responses and immune diseases, 
I decided to exploit the interaction between CXCL5 and CXCR2 to create a new tool to 
selectively target CXCR2+ immune cells. In this way using CXCL5 decorated NPs it’s 






CXCR2 chemokine receptor structure. Representation of the binding sites of receptor, 




2. Aim of the work  
In nanotechnology field, the selective targeting is still considered a challenge. It is very 
difficult to target in an active way cancer cells or a particular cell population, avoiding 
side effects on healthy cells. In particular, in my PhD project I decided to study and 
investigate this topic. The aim of my PhD project was to find a strategy to target in an 
active way a specific leukemia cell population (THP-1 cells). To get this goal, I adsorbed 
and covalently bound the chemokine CXCL5 on fluorescently labeled amino-
functionalized and PEGylated SiO2 NPs to precisely targeting CXCR2+ immune cells. 
My results provide the proof of principle that chemokine decorated nanomaterials 
enhance cellular uptake and allow precise cell subset localization. The possibility to aim 
at selective chemokine receptor-expressing cells can be beneficial for the different 
diseases involving immune system. 
3. Results and discussion 
3.1 Synthesis of 50 nm FITC-SiO2 Nanoparticles 
Silica (SiO2) particles can be produced in a very precise manner in the nano-metric scale. 
Size, shape, and surface properties, such as charge or hydrophobicity, can be finely tuned 
to increase their biocompatibility [79]. Many features of  SiO2  NPs  allow them to be 
used as reliable models for drug delivery systems [103]. Furthermore, fluorescent dyes or 
quantum dots can be easily entrapped or linked onto the NP surface for imaging purposes 
[103]. NP-coating polymers can also be used to reduce particle aggregation and increase 
their availability for target cells. Among the several biocompatible polymers, PEG shows 
many advantages, the most important of which are the reduced affinity to bind proteins  
[118] and the antifouling activity [119]. PEGylation of drugs and nanocarriers usually 
increase their circulation half-lives by decreasing their susceptibility to phagocytosis  
[77]. So, to endow NPs with “stealth” properties, the modification of their surfaces with 
PEG has become a popular method  [120][121][122][123][9]. SiO2 NPs were preferred 
as prototype particle due to the past and current expertise of the IIT-Nanobiointeractions 
and Nanodiagnostics Lab [103][124]. In particular fluorescent SiO2 NPs were synthesized 
using the Stöber method [82] adding fluorescein isothiocyanate (FITC) that reacts with 
APTMS and creates a FITC-conjugate. The following reaction with TEOS forms the 







Synthesis of FITC-SiO2 NPs using the Stöber method. Schematic representation of the 
different steps for the preparation of SiO2 NPs [125]. 
 
3.2 SiO2 NPs characterization 
Synthesized SiO2 NPs are characterized using different technique. To evaluate size and 
surface charge was used dynamic light scattering (DLS) analysis, for the morphology and 
the state of aggregation the transmission microscopy analysis (TEM). EDS analysis was 
used to evaluate the amount of N, C, O atoms present on NPs, CD to highlight important 
characteristics of protein secondary structure and conformational changes. To evaluate 
NPs uptake in cells was used the flow cytometry. 
3.2.1 Transmission electron microscopy analysis 
Transmission electron microscopy (TEM) is a microscopy technique in which a beam of 
electrons is transmitted through a specimen to form an image. The specimen is most often 
an ultrathin section less than 100 nm thick or a suspension on a grid. An image is formed 
from the interaction of the electrons with the sample as the beam is transmitted through 
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the specimen. The image is then magnified and focused onto an imaging device, such as 
a fluorescent screen [126]. In particular, I used this technique to evaluate the size, 
morphology and the state of aggregation of the SiO2 NPs (Figure16). The images show 
that NPs are spheroidal, their size is 50 nm in average and are monodispersed. 
 
Figure 16. 
                                                    
 
TEM analysis of SiO2 NPs in ethanol.  
 
3.2.2 Dynamic light scattering and zeta potential analysis 
DLS is a technique that can be used to determine the size distribution profile of small 
particles in suspension or polymers in solution [127]. A monochromatic light source, 
usually a laser, is shot through a polarizer and into a sample. The scattered light then goes 
through a second polarizer where it is collected by a photomultiplier and the resulting 
image is projected onto a screen. In particular temporal fluctuations are usually analyzed 












Schematic representation of DLS instrumentations [128]. 
Zeta potential is a scientific term for electrokinetic potential in colloidal dispersions. The 
usual units are volts (V) or millivolts (mV). Zeta potential is the potential difference 
between the dispersion medium and the stationary layer of fluid attached to the dispersed 
particle. It is widely used for quantification of the magnitude of the charge and it is a key 
indicator of the stability of colloidal dispersions. The magnitude of the zeta potential 
indicates the degree of electrostatic repulsion between adjacent, similarly charged 
particles in a dispersion. For molecules and particles that are small enough, a high zeta 
potential will confer stability and dispersion will resist to the aggregation. When the 
potential is small, attractive forces may exceed this repulsion and the dispersion may 
break and flocculate. So, colloids with high zeta potential (negative or positive) are 
electrically stabilized while colloids with low zeta potentials tend to coagulate or 
flocculate [129][130]. DLS and Zeta potential analysis were performed to characterize 
the synthesized NPs in suspension. SiO2 NP size was around 60 nm and have a negative 
surface charge. The size distribution was calculated measuring with Image J software the 










          






Histograms of size distribution in nm. D value (Diameter) reports the Average ± 
Standar deviation (SD) in nm [131]. 
 
3.3 Synthesis and characterization of PEGylated SiO2 NPs 
Coating nanoparticles surface with polymers like polyethylene glycol (PEG), 
polyethylene oxide hinders the binding of plasma proteins (opsonization) and prevents 
particle degradation. I functionalized SiO2 NP surface with PEG hiding the silanol groups 
and stabilizing the colloidal particles with the final aim to avoid opsonization and reduce 
specific particle sequestration by macrophage. During the synthesis of SiO2 NPs, the 




ethoxy groups creates siloxane bridges (Si–O–Si) that are able to form silica structure. In 
particular, Silane PEG-NH2 was used to favor the reaction between the silane group on 
the PEG chain with the silane group on SiO2 NPs. These particles were characterized by 
TEM and DLS. The images show the presence of a PEG shell around the silica surface 
(Fig. 21). Moreover, the graphs in Figure 21 highlight an increase of NP size and a 





Schematic synthesis of PEGylated SiO2 NPs using silane-PEG-NH2.  The reaction is 




Silane-PEG-NH2 NPs                                          
                                 
         
TEM analysis of PEG- NH2 NPs previously resuspended in water. In the figure, it is 












        
Evaluation of hydrodynamic diameter and surface charge of NH2-PEG-SiO2 NPs. 
After the coupling with PEG, the size increases and surface charge becomes less negative. 
3.3.1 Ninhydrin assay 
The ninhydrin assay was performed to evaluate the presence of amine groups in NH2 –
PEG NPs. Ninhydrin (2,2-dihydroxyindane-1,3-dione) is a chemical used to detect 
primary and secondary amines. When the compound reacts with free amines, a deep blue 
or purple color known as Ruhemann's purple is produced. To generate the ninhydrin 
chromophore (2-(1,3-dioxoindan-2-yl)iminoindane-1,3-dione), the amine is condensed 
with a molecule of ninhydrin to give a Schiff base. At this step, there must be a α hydrogen  
to form the Schiff base. Therefore, amines bound to tertiary carbons do not react further 
and thus are not detected. The reaction of ninhydrin with secondary amines gives an 
iminium salt, which is also colored, and this is generally yellow–orange in color [132]. 





to purple, due to the presence of amine in PEG chemical structure, confirming the 









Ninhydrine assay of SiO2 and NH2-PEG NPs to evaluate the presence of primary 
and secondary amines. The samples are dropped on a TLC and add to a solution of 
ninhydrin, butanol and acetic acid. The NH2-positive sample (NH2-PEG NPs) changes 
color from yellow to purple. 
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3.3.2 Coupling between Rhodamine isothiocyanate and Silane-PEG-NH2 NPs 
To further demonstrate the presence of PEG onto the SiO2 NPs, the coupling between the 
amine group present on PEGylated NPs and the isothiocyanate group of the 
isothiocyanate-rhodamine was performed. The fluorescence was evaluated by confocal 
microscopy and PEGylated NPs resulted more fluorescent than SiO2  NPs on average 






Schematic representation of the coupling between NH2-PEG Nps and Rhodamine 







3.3.3 EDS analysis to evaluate the presence of N atoms in NH2-PEG NPs  
Energy-dispersive X-ray spectroscopy (EDS, EDX, EDXS or XEDS) is an analytical 
technique used for the elemental analysis or chemical characterization of a sample. It is 
based on the interaction of X-rays with a sample containing elements with exclusive 
atomic structure allowing a unique set of peaks on its electromagnetic emission spectrum. 
At rest, an atom within the sample contains unexcited electrons in discrete energy levels 
or electron shells bound to the nucleus. The incident beam may excite an electron in one 
of the inner shells, ejecting it and creating an electron hole. An electron from an outer, 
higher-energy shell then fills the hole, and the difference in energy between the higher-
energy shell and the lower energy shell may be released in the form of an X-ray. The 
number and energy of the X-rays emitted from a specimen can be measured by an energy-
dispersive spectrometer and EDS allows the elemental composition of the specimen to be 
measured [133]. EDS analysis was used to further characterize the presence of Silane-
PEG-NH2 on Silica NPs evaluating the amount of N, C, O atoms present in the sample. 
Figure 26 shows the elemental analysis of NPs. N element is present only in NH2 -PEG 
NPs and not in SiO2 NPs, confirming the coupling with the polymer. 
 
Figure 26. 
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EDS analysis on silica and NH2-PEG NPs. Quantification in percentage by weight  of 
different atoms of C,O,N on SiO2 NPs and NH2-PEG NPs. 
 
3.4 CXCL5 functionalization  
The opportunity to choose specific polypeptides or proteins, whose cognate receptors are 
expressed by immune cells, can be exploited for specific immune cell targeting. To 
achieve this goal, I chose the chemokine CXCL5 to be bound onto the NPs. CXCL5 
cognate receptor, CXCR2, is overexpressed in THP-1 cell line used as target cell model. 
I followed two strategies: CXCL5 was either covalently linked or absorbed on the PEG-
NP surface. The covalent coupling (A) was chosen to favor the right orientation of the 
chemokine on NH2-PEG NPs. The coupling reagent EDC/NHS allows the activation of 
the carboxylic groups of CXCL5 that reacts with the amine present of NPs surface. In this 
way, the amino terminal binding domain of CXCL5 can interact with CXCR2. In a second 
reaction (B) CXCL5 is adsorbed directly on NH2-PEG NPs creating a CXCL5-protein 

















Schematic representation of CXCL5-PEG NPs synthesis. 
 
3.5 Characterization of NH2-PEG NPs 
3.5.1 DLS and Zeta potential analysis 
Dynamic light scattering (DLS) and Zeta potential analysis were performed to evaluate 
the dispersion characteristics and the surface charge of the synthesized NPs. SiO2 NPs’   
size was around 60 nm on average. NH2-PEG NP surface charge become more positive 
after the covalent coupling or adsorption of  CXCL5 due to the presence of the chemokine 
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CXCL5 NH2- PEG NPs 
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Evaluation of dispersion and surface charge of PEG-NH2, CXCL-5 and adsorbed 
CXCL-5 NPs by DLS analysis. 
3.5.2 Circular dichroism 
Circular dichroism (CD) is a technique that evaluate the differential absorption of left-
and right-handed light of optically active chiral molecules. CD spectroscopy has a wide 
range of applications in many different fields. Most notably, UV CD is used to investigate 
the secondary structure of proteins. UV/Vis CD is exploited to investigate charge-transfer 
transitions. Near-infrared CD is used to evaluate geometric and electronic structure by 
68,69 nm -41,2 mV  
61,63 nm -34,6 mV   




probing metal d→d transitions. Vibrational circular dichroism, which uses light from the 
infrared energy region, is employed for structural studies of small organic molecules, and 
most recently proteins and DNA. In particular, the alpha helix of proteins and the double 
helix of nucleic acids have CD spectral signatures representative of their specific 
structures. The far-UV (ultraviolet) CD spectrum of proteins can reveal important 
characteristics of their secondary structure like the alpha-helix conformation, the beta-





Schematic representation of CD spectroscopy technique. Monochrome light passed 
through a Photo Elastic Modulator (PEM), which converts the linear polarized light into 
alternating left and right-handed polarized light. The two polarizations are differently 
absorbed, and the difference in absorption is detected with a Photo Multiplier Tube (PMT) 
[135]. 
 
In my project, CD was performed to assess the presence of CXCL5 on NP surface and to 
evaluate its conformation through β-sheet and α-helix structure analysis. The results 
showed the presence of the chemokine on NPs, but with a different conformation 
compared to the native chemokine as effect of the several interactions with the 
nanomaterial (size, shape and charge). In Fig. 30 it is possible to appreciate the typical 
peaks of α- helix (negative bands at 222 nm and 208 nm and a positive band at 193 nm)  
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and β-sheets (bands at 218 nm and positive bands at 195 nm) in CXCL5-PEG NPs, which 
are not present in the non-functionalized NPs. In the case of adsorbed chemokine, the 








        

































                                                                  
Circular dichroism analysis of different Silica NPs. Different CXCL5 conformation 
after the interaction with NH2-PEG NPs. 
 
3.6 Biological assays  
3.6.1 Silica NPs uptake analysis by flow cytometry 
Flow cytometry is a technique used to detect and measure physical and chemical 
characteristics of a population of cells or particles. Measurable cell parameters include: 
geometric properties, such as cell size (diameter, surface area, and volume); physiological 
properties, such as membrane potential, integrity, and vitality; and quantities of DNA, 
RNA, cytokines, surface antigens,nuclear antigens, enzymes, proteins. In particular, flow 




























cytometer is composed of five main components: a flow cell, a measuring system, a 
detector, an amplification system and a computer for analysis of the signals. The fluidics 
system includes a flow cell, where the sample fluid is injected. The flow cell requires 
sheath fluid to carry and align the cells or particles so that they pass through a narrow 
channel and into the laser intercept (light beam). The optics system consists of various 
filters, light detectors, and the light source, which is usually a laser line producing a single 
wavelength of light at a specific frequency. Lasers are available at different wavelengths 
ranging from ultraviolet to far red. The detector and analog-to-digital conversion (ADC) 
system converts analog measurements of forward-scattered light (FSC) and side-scattered 
light (SSC) into digital signals that can be processed by a computer. Forward scattered 
light is refracted by a cell in the flow, larger cells will have a stronger forward scatter 
signal. Side scattered light passes from the illumination source into the flow channel, is 
refracted by cells in a direction that is outside of the original light path and it is usually 
used to make a determination regarding the granularity and complexity of the cell. Highly 
granular cells with a large amount of internal complexity, like neutrophils, will produce 
more side-scattered light. The process of collecting data from samples using the flow 
cytometer is termed 'acquisition'. Acquisition is mediated by a computer physically 
connected to the flow cytometer and a software that is capable of adjusting parameters 





Schematic representation of flow cytometry instrument [137]. 
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I used flow cytometry to study the interaction of fluorescent SiO2 NPs with immune cells 
(THP-1). The cell fluorescence and side-scattered light increase after incubation with NPs 
and allowed us to define time and concentration dependence of nanoparticle-cell 
interaction.[104]. Fig. 32 shows the internalization of different SiO2 NPs after 45 minutes 
of incubation in THP-1 cells. Cell uptake of CXCL5-NH2 – PEG NPs is higher compared 
to NH2 –PEG NPs due to the right disposition of the protein on NPs surface. When the 
protein is adsorbed on NPs internalization is reduced, possibly due to chemokine 






Uptake of different Silica NPs in THP-1 cells without serum evaluated by flow 
cytometry. The bars represent the fold increase fluorescence  after the administration of 
50 µg/ml of SiO2 NPs. Error bars represent the mean at least of three independent 
experiments ± SD. * P< 0,05   
 
3.7 Optimization of the coupling between CXCL5 chemokine and NH2- SiO2 NPs 
Due to the difficult solubility of the Silane-PEG-NH2 compound  and NP aggregation after 
EDC/NHS reaction, CXCL5 NPs’ synthesis was optimized by linking covalently CXCL5 
directly onto the aminated surface of SiO2 NPs. Since the receptor binding site of 
chemokines is at the N-terminus of the protein, I previously charged the NPs surface with 
positive amino groups to favorite the covalent binding of the COOH chemokine terminal 
group to the NP surface. Then, I functionalized NH2-SiO2 NPs with CXCL5 (Fig. 33). 
52 
 
The amination was obtained treating SiO2 NPs with APTMS and acetic acid. Suddenly, 
the covalent coupling was achieved using a different coupling reagent to avoid NPs’ 
aggregation. In particular NH2-SiO2 NPs were mixed with CXCL5 in the presence of 4-





Schematic representation of covalent coupling between NH2 -SiO2 NPs and CXCL5. 
 
3.8 Adsorption of CXCL5 on NH2-SiO2 NPs 
Numerous NMs show the intrinsic property to adsorb specific proteins present in 
biological fluids (e.g. blood) that can be used as targeting molecule to drive cell 
localization [64]. Although the formation of a selective protein corona is attractive, some 
concerns regarding the non-advantageous peptide orientation or the presence of 
conformational changes due to the chemical and physical interactions with the particle 
surface cannot excluded [65]. However, I also investigated the effect of the chemokine as 
a protein corona around NP Cores (A) and NH2-SiO2 NPs (B). In particular CXCL-5 













Schematic representation of CXCL5 adsorption onto Silica NP cores 
 
3.9 SiO2 NPs characterization 
3.9.1 DLS analysis 
DLS and Zeta potential analysis were performed to evaluate the dispersion characteristics 
and the surface charge of the synthesized NPs. SiO2 NPs’ size was around 90 nm and 
surface charge was negative (-50 mV), NH2 – SiO2 NPs show a positive zeta potential 
and when CXCL5 is linked to the NPs, there is an increase in size and a reduction in 














Reported values of hydrodynamic diameters, polydispersion index and zeta 
potential of the NPs. 
3.9.2 Immunogold 
Immunogold labelling is a powerful technique to identify active sites and represents the 
best candidate probe to visualize proteins by TEM. In this technique gold nanoparticles 
conjugated with secondary antibodies bind primary antibodies that are able to recognize 









  Hydrodynamic 
diameter 
PDI Zeta potential 
SiO2 NPs 94,47 nm 0,12 -50,0 mV 
NH2 – SiO2 NPs 99,4 nm  0,18 29,8 mV 
CXCL5– SiO2 NPs 121 nm  0,18 16,8 mV 
Ads-CXCL5-SiO2 
NPs 
145,8 nm 0,24 23,9 mV 
Cores+CXCL5 
NPs 






Representation of the whole process of immunogold labelling.   
 
Immunogold staining was used to detect CXCL5 proteins on NH2-SiO2 NPs surface. 
Because of their electron density properties, gold nanoparticles (GNPs) can be easily 
revealed by electron microscopy and distinguished from the less electron-dense SiO2. To 
visualize the fine localization of proteins present on NPs, I used 10 nm gold NPs linked 
to a secondary antibody against anti-CXCL5. Some spots in side view apparently seem 








                              
 
Nanoparticles immuno-labelling. TEM images showing the epitope mapping of 
covalently bound CXCL5 on NPs surface by 10 nm immune-gold NPs (dark spots) [131]. 
 
3.10 CXCR2 expression and internalization  
To evaluate CXCR2 expression, THP-1 cultured in Fetal bovine serum (FBS) and Human 
Serum (HS) were incubated with fluorescently labelled antibody anti-CXCR2 and cell-
associated fluorescence was analyzed by flow cytometry (Fig 38 A). The results show 
higher expression in HS enriched medium than in THP-1 cultured in FBS. 
To evaluate receptor activity, THP-1 cells were starved in serum-free medium and then 
were treated with CXCL5 at different concentrations (100, 1000 nM). Subsequently the 
cells were incubated with fluorescently labelled antibody anti-CXCR2 and cell associated 
fluorescence was evaluated by flow cytometry (Fig. 38 B). The result highlight partial 
internalization (around 50%) of CXCR2 in THP-1 cells by CXCL5 at different 










A                                                                      B 
                      
 
CXCR2 expression by flow cytometry on THP-1 cells cultured in different 
conditions (A). Bars represent the median fluorescence intensity. Error bars represent the 
mean at least of three independent experiments ± Standard error of the mean (SEM).    
CXCR2 internalization (B). Bars represent the median fluorescence intensity (MFI) of 
APC-labelled anti-CXCR2 in the absence or presence of CXCL5. Error bars represent the 
mean at least of three independent experiments ± SEM [131]. 
 
3.11 SiO2 NPs internalization in THP-1 cells cultured in HS and FBS  
CXCL5-NP specific targeting properties were studied in CXCR2 expressing myeloid pro-
monocytic THP-1 cells [139][140]. I compared the cellular uptake of the CXCL5-NPs 
with non-functionalized positively charged NPs, in the absence or in the presence of 
serum during the incubation time.  The relatively short time incubation (45 minutes) has 
been chosen as longer time of cell exposure to NPs would have allowed unspecific 
internalization of both types of NPs invalidating the kinetic advantage of chemokine-
receptor binding for the CXCL5-NPs. Flow cytometry results showed > 4 times increased 
uptake of the CXCL5-NPs vs. NH2-NPs in serum-free medium (Fig.39 A). Internalization 
of CXCL5-NPs in complete medium was also noticeably enhanced, although less 
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pronounced than in serum-free condition. This reduction is likely due to the serum diverse 
protein corona reducing NPs interaction with cells. 
In figure B is shown the same type of experiment using THP-1 cultured in HS enriched 
medium. Flow cytometry results showed increased uptake of the CXCL5-NPs vs. NH2-
NPs following incubation without serum. Internalization of CXCL5-NPs in THP-1 cells 
in complete medium was also enhanced but less pronounced than in serum-free condition 











Silica NPs uptake in THP-1 cell lines in different medium conditions evaluated by 
flow cytometry. The bars represent the relative median fluorescence intensity (RMFI) 
after the administration of 50 µg/ml of SiO2 NPs. Error bars represent the mean at least 
of three independent experiments ± SEM. **** P< 0,0001 *** P< 0,0005 * P< 0,05 [131]. 
It’s very difficult to compare these results with other works present in literature, because 
is the first time that a chemokine is covalently linked to NPs surface to target in a selective 
way a receptor overexpressed in particular cell population. There are other works that 
have as main goal the targeting of receptors. In the work of Ying Xie et al. cyclam- and 
chloroquine-based polymeric CXCR4 antagonists are used to deliver functional siRNA 
and miRNA to cancer cells and block the CXCR4/ CXCL12 axis. These CXCR4 targeted 
nanomedicines carrying functional siRNA/miRNA represent a promising choice for 
combinational cancer therapy especially metastasis inhibition [141]. 
 
3.12 CXCL5 NPs displacement by CXCL5 pre-treatment. 
A further proof of CXCL5-NPs interaction with CXCR2 has been underlined by NP 
uptake in cells pretreated with high concentration of free CXCL5. In particular I pre-
treated THP-1 cells with 1µM CXCL5 and subsequently incubate the cells with both types 
of NPs. As shown in Fig. 40, CXCL5-NP internalization was reduced, whereas THP-1 
uptake of NH2-NPs revealed a statistically non-significant increase in average. I 
hypothesized that the presence of free chemokine in the medium could create a CXCL5 
corona facilitating the entrance of NH2-NPs. On the contrary, the moderate but 
statistically significant reduction of CXCL5-NPs internalization may be due to the 
agonist-mediated partial internalization of CXCR2 in THP-1 cells. As demonstrated in 
Fig 38 B, the administration of saturating concentrations (up to 1 µM) of CXCL5 
internalizes less than 50% of the receptor expressed on the surface. This event maybe is 
due to saturation of intracellular internalization mechanisms, for example β-arrestins 
pathway desensitization [142] or aberrant expression of this receptor in THP-1 cell line. 
These data clearly show the different behavior of CXCL5-NPs and NH2-NPs in the 










CXCL5 displacement by free CXCL5. Internalization of 50 µg/ml NPs in THP-1 cells 
pretreated or not with 1µM CXCL5. The bars represent RMFI of at least three 
independent experiments ± SEM. ** P< 0,001 [131]. 
 
3.13 CXCR2 expression and Silica NPs internalization in HeLa cells 
In order to study the targeting selectivity of CXCR2+ cells, I compared the uptake of NPs 
in CXCR2high THP-1 cells vs. CXCR2low HeLa cells. THP-1 and HeLa cells were 
incubated with anti-CXCR2 antibody for 15 minutes and cell-associated fluorescence was 
analyzed by flow cytometry. The results show that HeLa cells present lower expression 
of CXCR2 compared to THP-1 (Fig 41 A).  
In order to study the targeting selectivity of CXCR2+ cells, I compared the uptake of NPs 
in  CXCR2high expressing THP-1 cells vs. CXCR2low HeLa cells (Fig 41 B). Incubation 
of these two cell lines with functionalized and non-functionalized NPs displayed opposite 
results. In CXCR2low HeLa cells, I could not detect increased CXCL5-NPs internalization 
in respect of the control NPs. The result shown by flow cytometry and confocal 
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CXCR2+ cell preferential targeting of CXCL5-NPs. CXCR2 expression (A) and NPs 
uptake in THP-1 and HeLa cells in serum free conditions (B) evaluated by flow 
cytometry. The bars represent MFI and RMFI of at least three independent experiments 
± SEM [131]. 
3.14 Confocal microscopy of NH2-SiO2 and CXCL5-SiO2 NPs in THP-1 and HeLa 
cells  
Confocal microscopy is used to resolve the detailed structure of specific object within the 
cells. In particular, biological samples are often treated with fluorescent dyes to make 
selected objects visible. Confocal laser-scanning microscope (CLSM) illuminates the 
sample with lasers of various wavelengths (available from UV to infrared) that produce 
an intense beam that can be focused down to a tiny spot. Galvanometer mirrors within the 
scan head guide the laser beam through the objective lens and back and forth and up and 
down across the specimen. To form a 3D data set, the focus can then be changed and 
another image generated at the new focal depth. Successive images are collected at 
various focus depths to generate a 3D image stack. Modern confocal microscopes use 
acousto-optic tunable filters (AOTFs) to rapidly turn lasers on and off, attenuate laser 
light, and to select which color of laser light is exciting the sample. To visualize the 
specimen by eye or using a camera, the fluorescence from the sample is collected by the 
objective lens, rescanned by the galvanometric mirrors, and then focused through a 
confocal pinhole onto a photomultiplier tube (PMT).The PMT has a light-sensitive 
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photocathode that converts photons into photoelectrons that are then amplified by a series 
of dynodes. As the PMT detects the fluorescence pixel by pixel across the sample, the 






Schematic diagram of the confocal laser-scanning microscope (CLSM). The 
excitation laser beam light path (A) and emission light path (B). The solid blue lines in 
(A) represent the excitation laser that is focused onto the specimen. The solid green lines 
in (B) show that emission light from the focal plane passes through the pinhole aperture 
and is detected by the photomultiplier tube (PMT). The dashed gray lines show that out-
of-focus light will be blocked, will not pass through the pinhole, and will not be detected 










Basic CLSM light path. Schematic diagram of the CLSM light path with blue 
excitation light selected by the AOTF. The light is focused onto the sample by the 
objective lens and then scanned across the sample by the x and y galvanometer mirrors. 
Emission light is focused by the objective lens, descanned by the mirrors and reflected 
toward the detection light path by the primary dichroic mirror. In-focus light is selected 
by the pinhole aperture. The secondary dichroic mirror splits the green emission light and 
directs it to be detected by PMT1, and the red emission light passes and is detected by 
PMT2 [143]. 
I used confocal microscopy to visualize the presence of fluorescent SiO2 NPs inside the 
cells. In particular, to confirm the data obtained by flow cytometry, THP-1 and HeLa cells 
were treated with NH2 – SiO2 and CXCL5-NPs for 45 minutes and the internalization was 
evaluated by confocal microscopy. Figures A-C show THP-1 and HeLa pre-treated with 
NH2–SiO2 NPs. The nuclei were stained with Hoersch dye and lysosomes with 
lysotracker for THP-1 instead for HeLa the cytoscheleton was stained with phalloidin red.  
Both the cell lines don’t internalized NH2 – SiO2 NPs. Maybe it is due to the fact that 45 
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minutes are a short time to favor the internalization of nanoparticles that enter the cells 
by endocytosis. 
Figures B-D show the cells pre-treated with fluorescent CXCL5-NPs. In THP-1 cells it’s 
possible to observe the presence of nanoparticles inside the cells because they enter the 
cells through the receptor mediated uptake and as demonstrated before, CXCR2 is very 
high expressed on THP-1 cell membranes. Instead for HeLa cells, because of the very 
low expression of CXCR2, these cells don’t internalize CXCL5-NPs demonstrating the 
preferential targeting of CXCR2+ cell by CXCL5 decorated NPs. 
The intracellular localization of the particles was also confirmed by 3D confocal 
microcopy (Fig.45) highlighting the presence of CXCL5-NPs inside the cells, many of 
them not co-localize with lysosomes, as predictable by the short time incubation. 
 
Figure 44. 
                                
 
 
A-B:  Confocal microscopy of THP-1 cells treated with 50 µg/ml of NH2 SiO2–NPs and 
CXCL5-SiO2 NPs for 45 minutes. Blue: nuclei; red: lysosomes; green: NPs. C-D: 
Confocal microscopy of HeLa cells treated with 50 µg/ml of NH2– SiO2 NPs and CXCL5- 




        
3d images obtained by confocal analysis of CXCL5 SiO2 NPs uptake in THP-1 
cells.  
 
3.15 Uptake of NH2-SiO2 and Ads CXCL5-SiO2 NPs in THP-1 cells cultured in 
FBS and HS 
The internalization of NH2 –SiO2 and Ads CXCL5-SiO2 NPs in THP-1 cells cultured in 
FBS and HS was evaluated by flow cytometry. The results (Figure 46 A) demonstrate 
that both without and with serum Ads CXCL5-SiO2 NPs show an increased 
internalization compared with the NH2-SiO2 NPs due to the presence of the protein on 
NPs surface. In particular, without the presence of serum there is an increase in cell 
fluorescence, maybe due to the presence of NPs aggregates, instead with serum, the 
colloidal system became more stable due to the presence of protein in serum avoiding the 
formation of aggregates. Even if the protein is adsorbed on the surface in a randomly way, 
it is able to interact with its cognate receptor, favoring NPs uptake. 
In Figure 46 B when cells are cultured in HS, internalization of Ads CXCL5-SiO2 NPs 
was noticeably enhanced than NH2-SiO2 NPs. Ads CXCL5-SiO2 NPs in cells treated 
without serum present an opposite behavior compared with the cells cultured in FBS. It 
is due to the different condition in which cells are cultured, because the proteins contained 
in HS are different from the ones that are present in FBS and this fact could affect the 














Silica Nps uptake in Thp-1 cell lines in different medium conditions evaluated by 
flow cytometry. The bars represent the RMFI after the administration of 50 µg/ml of 
SiO2 NPs. Error bars represent the mean at least of three independent experiments ± SEM. 
**** P< 0,0001 ** P< 0,01  * P< 0,05 
 
3.16 Uptake of Cores and Cores + CXCL5-SiO2 in THP-1 cells cultured in FBS 
and HS 
In Fig. 47 A CXCL5 was adsorbed on SiO2 NPs (Cores) and the internalization in THP-
1 cultured in FBS was evaluated by flow cytometry. The results show that internalization 
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of functionalized NPs was compared with the silica cores as expected by chemokine 
functionalization. In particular, due to the different surface charge of SiO2 NPs vs NH2 
SiO2 NPs, in presence of serum functionalized NPs show a higher internalization 
compared with the condition in which cells are cultured without serum. Maybe, the 
presence of serum destabilizes the colloidal suspension of NPs creating aggregates in 
cells. 
In Fig. B, when cells are cultured in HS, NPs present the same behavior of the previous 
experiment. Interestingly, because of the presence of human CXCL5 in the medium, the 
uptake of functionalized NPs is reduced because human CXCL5 screens the effect of 










Silica NPs uptake in Thp-1 cell lines in different medium conditions evaluated by 
flow cytometry. The bars represent the RMFI after the administration of 50 µg/ml of 
SiO2 NPs. Error bars represent the mean at least of three independent experiments ± SEM. 
**** P< 0,0001 *** P< 0,0005 
My results demonstrated a big increase in NPs internalization after the adsorption of 
CXCL5 on NPs surface. Similar results are shown in the work of Melissa Santi et al. 
[144]. The transferrin receptor (TfR) is a promising target in cancer therapy owing to its 
overexpression in most solid tumors and on the blood−brain barrier. In the work, 
transferrin-mediated endocytosis of gold nanoparticles by modifying their protein corona 
of transferrin is promoted. The internalization of gold nanoparticles is strongly dependent 
on the amount of the peptide PepN-Tf2 on the surface, in fact the internalization of AuNP-
10 (10% w/w of peptide) was 44-fold greater compared with what observed for AuNP 
not functionalized. The advantage, in my project to use Ads CXCL5 NPs is that these 
protein-decorated nano-tools showed enhanced uptake and precise receptor-mediated cell 
subset localization. Instead, in the work mentioned above, NPs could be used for different 
types of cancer but not for a specific cell population. 
 
4. Methods and Materials 
4.1 SiO2 Nanoparticles preparation, functionalization and characterization 
4.1.1 Synthesis of 50 nm FITC-SiO2 NPs 
Briefly, N-1-(3-trimethoxysilylpropyl)-N‘-fluoresceyl thiourea (FITC-APTMS) 
conjugate solution was prepared by dissolving 2 mg fluorescein isothiocyanate (FITC) in 
1 ml anhydrous ethanol and immediately mixed with 10 µl of (3-Aminopropyl) 
trimethoxysilane (APTMS) under shaking  at room temperature for 4 h in the dark. Under 
nitrogen atmosphere, 25 ml of ethanol was added to 1 ml of aqueous ammonia (28%) and 
stirred. 950 µl Tetraethyl orthosilicate (TEOS) was then mixed with the conjugate 
solution and the reaction was stirred at 600 rpm at room temperature for further 20 h in 
darkness. The resulting particles were washed three times by centrifugation and 
resuspension in Ethanol using bath sonication and ultimately resuspended in ethanol to 
reach a final particle concentration of 10 mg/ml [131]. 
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4.1.2 Nanoparticles surface amination 
FITC-SiO2 NPs were centrifuged and redispersed in water, then 0,5% of acetic acid and 
1% of APTMS were added. The reaction was taken under stirrer for 1 h at room 
temperature. NPs were washed twice and redispersed in water [131]. 
4.1.3 Pegylation of Silica NPs 
4 ml of 50 nm FITC-SiO2 NPs were centrifuged and redispersed in 1,6 ml of ethanol 
anhydrous, then was added 1,6 ml of Silane-PEG-NH2 (400 µM final concentration) and 
800 µL of ammonia (28%). The reaction was taken under nitrogen atmosphere for 16 h. 
NPs were centrifuged and washed twice with a solution of ethanol/dimethyl sulfoxide 
(DMSO) 1:1, once with ethanol and redispersed in water . 
4.1.4 Ninhydrine assay 
To evaluate the presence of secondary amine in NH2-PEG NPs, ninhydrine assay was 
performed. Ninhydrine is able to bind the primary and secondary amines, changing the 
color from yellow to purple in presence of amino groups. The samples are dropped on a 
TLC and then they are put in a solution of ninhydrine, butanol and acetic acid. The 
samples changes the color from yellow to purple in the presence of PEG. 
4.1.5 Coupling between Rhodamine isothiocyanate and NH2 –PEG NPs 
200 µl of NH2-PEG NPs and SiO2 NPs were centrifuged and redispersed in 200 µl of 
ethanol, then was added 50 µl of Rhodamine Isothiocyanate (200 nM final concentration). 
The reaction was stirred for 3,30h and then the particles were centrifuged and washed 
once in ethanol and three times in water. To evaluate FITC and Rhodamine fluorescence, 
images are acquired using the laser 488 for FITC, and the laser 543 for Rhodamine 
isothiocyanate, using the confocal LSM710 ZEISS with oil objective 100X. 
4.1.6 Coupling with chemokine CXCL5   
NH2-PEG NPs were mixed with the chemokine CXCL5, then 1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride) (EDC) and N-Hydroxysuccinimide 
(NHS) were  added in MES ( 2-(N-morpholino)ethanesulfonic acid ) and stirred at room 
temperature for 2h. The solution was centrifuged once and washed many times with 
water. Finally NPs were redispersed in water. 
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4.1.7 Optimization of Covalent Coupling with CXCL5 chemokine  
NH2-SiO2 NPs (500 µg/ml) were mixed with CXCL5 (4 µM) in water, then 4-(4,6-
Dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride (DMTMM 10 µM) was 
added and the reaction was stirred at room temperature for 4h. The solution was then 
centrifuged twice (1100 rpm for 1,5 minutes) using 100 kDa Amicon tubes (Merck 
Millipore) and the NPs were redispersed in water at the same initial concentration [131]. 
4.1.8 Adsorption of CXCL5 on Silica NPs 
Silica NPs (500µg/ml) and NH2- SiO2 NPs were mixed with CXCL5 (4µM), in water and 
stirred at room temperature for 2h. 
4.1.9 Transmission electron Microscopy 
NPs were characterized by TEM using a JEOL JEM-1400 Plus (Jeol, Akishima-shi, 
Japan), with LaB6 thermionic source with an acceleration voltage of 120 kV. Images were 
acquired using a Gatan CCD camera Orius 830 (2048 x 2048 active pixels). The particle 
size distribution was obtained by manually measurement of the diameter of at least 500 
NPs using ImageJ software. 
4.1.10 Size and electrophoretic mobility.  
Dynamic light scattering (DLS) measurements were performed on a Zetasizer Nano ZS90 
(Malvern, USA). 20 µl of nanoparticle dispersion sample were taken and dispersed in 980 
µl Milli Q water. Measurements were made at 25 °C using disposable polystyrene 
cuvettes. The refractive index (Ri) and the adsorption index (Rabs) of silica material were 
1,47 and 0.000 respectively, according to the standard operating procedure (SOP) for 
measurement of hydrodynamic Size-Distribution and Dispersion Stability by Dynamic 
Light Scattering (DLS). After size measurement, particles were transferred to zeta 
potential cuvette (disposable capillary zeta cell) and the measurements were made used 
the Smoluchowski model [131]. 
4.1.11 Nanoparticle Immunolabelling  
Plasma-cleaned formvar carbon film-coated 300 mesh copper grids (Electron Microscopy 
Sciences) were incubated 2 min with 5-μL drops containing CXCL5-SiO2 NPs. Dilutions 
were optimized for each SiO2 NPs concentration. After two washing steps with 50-μL 
drops of washing buffer (0.1% BSA in PBS), samples were incubated with 50-μL drops 
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containing buffer A (1% BSA in PBS) for negative control or Rabbit Anti-Human 
CXCL5 primary antibody (Peprotech, USA) (8 μg/mL in buffer A) in a wet chamber for 
3 h at room temperature. After five washes with washing buffer, SiO2 NPs were incubated 
with 20-μL drops of 1:40 dilutions of the secondary antibody (goat anti-rabbit IgG-gold 
conjugate, (H&L) EM-grade, 10-nm particle size (Electron microscopy science) for 30 
minutes in washing buffer. The system was then washed five times with five drops of 
washing buffer, followed by five washes with water drops [131]. 
4.1.12 EDS analysis 
EDS characterization was performed on a high resolution scanning electron microscope 
(SEM) Jeol JSM-7500F equipped with a cold field emission gun using  an Oxford X-Max 
80 system with a silicon drift detector (SDD) having an 80 mm2 effective area. The 
analyses were done with an accelerating voltage of 5/10 kV. 
4.1.13 Circular Dichroism 
CD spectra were recorded using a JascoJ-1500 spectropolarimeter in a 1.0 cm quartz cell 
at room temperature. The spectra were recorded from 300 to 190 nm, with a band width 
of 1 nm, a time constant of 16 s, and a scan rate of 10 nm/min. Spectra were recorded 
subtracting them from blank samples. 
4.2 Biological assays 
4.2.1 Cell culture 
THP-1 cells (ATCC Manassas, VA, USA) were cultured in RPMI-1640 (Thermo Fisher 
Scientific) supplemented with 10% fetal bovine serum (FBS) or 5% human serum (HS) 
(Thermo Fisher Scientific, Waltham, MA, USA), 1% Penicillin-Streptomycin (Sigma-
Aldrich, Saint Louis, MO, USA) and 0.05 mM 2-mercaptoethanol (Thermo Fisher 
Scientific, Waltham, MA, USA). HeLa cells (ATCC Manassas, VA, USA) were cultured 
in DMEM (Thermo Fisher Scientific) supplemented with 10% FBS and 1% Penicillin-
Streptomycin. Both the cell lines were grown at 37°C in a 5% CO2 humidified atmosphere 
[131]. 
4.2.2 Confocal microscopy 
THP-1 and HeLa cells were seeded on a 4 well NUNC Lab-Tek Chambered Coverglass 
(Thermo Fisher Scientific) and incubated in serum free medium with the proper SiO2  NPs 
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at the concentration of 50 µg/ml for 45 minutes, then washed twice. THP-1 cells were 
incubated with LysoTracker and Hoechst 33342 (Thermo Fisher Scientific) at a 
concentration of 5 μg/mL for 15 minutes at 37 °C. After the staining, the cells were 
washed twice and Live Cell Imaging Medium (Thermo Fisher Scientific) was added for 
living cell analysis. HeLa cells were fixed with 4% paraformaldehyde for 15 minutes at 
room temperature, permeabilized with 0.1% Triton for 30 minutes and blocked with 
PBS/1% BSA for 30 minutes. The cells were then incubated with 0.1 nM Rhodamine 
Phalloidin for actin microfilaments staining and 5 μg/mL Hoechst 33342 (Thermo Fisher 
Scientific) for 2 h at room temperature in the dark. Confocal microscopy images were 
acquired by a Leica SP5 Inverted confocal microscope with a 63 × oil immersion 
objectives, 405, 495 and 561 nm excitation laser wavelengths and a resolution 1024 × 
1024 pixels [131]. 
4.2.3 CXCR2 receptor expression 
THP-1 cells (5 x 10^5 cells ml-1) cultured both in FBS and HS and HeLa cells, were 
centrifuged at 300 g for 5 min, resuspended in RPMI 0.5% BSA (Miltenyi Biotec) and 
incubated with APC-conjugated mouse anti-human CXCR2 antibody (Miltenyi Biotec) 
at the manufacturer’s recommended concentration for 15 min on ice in the dark, then 
washed and resuspended in RPMI. Cell-associated fluorescence was analyzed by flow 
cytometry with MACS Quant Analyzer, gating the living cells based on light forward 
scattering (FSC) and side scattering (SSC). 100 000 events per sample were acquired 
[131]. 
4.2.4 Internalization capability of CXCR2 receptor  
THP-1 cells (2 x 10^5) were starved in serum-free medium containing 0,5% of BSA for 
1h. Then the cells were treated with CXCL5 at different concentrations (0,1; 1 µM) for 
1,30h, washed and incubated for 15 minutes with APC-conjugated mouse anti-human 
CXCR2 antibody (Miltenyi Biotec). Then the cells were washed and analyzed by FACS 
MACS Quant Analyzer (Miltenyi Biotec, Bergish, Germany) using MACS Quantify 




4.2.5 Uptake of Silica NPs  
2 x 10^5 THP-1 cells cultured both in FBS and HS, were placed inside  a 48 -well plate 
and incubated with 50 µg/mL of  different Silica NPs at 37 °C and 5% CO2 for 45 minutes 
in different types of culture media. After incubation, samples were washed twice at 4°C 
with RPMI medium to remove non-internalized NPs. The effect of Silica NPs 
internalization  was evaluated by flow cytometry with MACSQuant Analyzer (Miltenyi 
Biotec, Bergish, Germany) using MACSQuantify software [131]. 
4.2.6 CXCL5 NPs displacement by CXCL5 pre-treatment. 
THP-1 cells (2 x 10^5 cells ml -1) were treated with 1 µM CXCL5 in serum free medium 
containing 0,1 % of bovine serum albumin (BSA) for 45 minutes and incubated with 50 
µg/ml of  NH2– SiO2 NPs and CXCL5- SiO2 NPs  for 45 minutes. After incubation, 
samples were washed twice to remove non-internalized NPs and resuspended in RPMI 
0,1% BSA. Cell-associated fluorescence was analyzed by flow cytometry with FACS 
MACS Quant Analyzer (Miltenyi Biotec, Bergish, Germany) using MACS Quantify 
software. 
4.2.7 Uptake of Silica NPs in THP-1 and HeLa cells 
2 x 10^5 THP-1 cells and HeLa , were incubated with 50 µg/mL of  different Silica NPs 
at 37 °C and 5% CO2 for 45 minutes in medium without serum. After incubation, samples 
were washed twice at 4°C with RPMI medium to remove non-internalized NPs. The effect 
of SiO2 NPs internalization was evaluated by flow cytometry with MACSQuant Analyzer 
(Miltenyi Biotec, Bergish, Germany) using MACSQuantify software [131].  
 
4.3 Statistical analysis 
Data were expressed as mean ± SEM. For statistical analysis GraphPad Prism 8 software 
wad used (San Diego, California, USA). p-values were calculated using two-tailed t-test 





One major challenge in nanomedicine is to find a way to selectively deliver NPs to 
diseased tissues. Functionalizing nanoparticles is a widely-used technique that allows the 
conjugation with targeting ligands, which possess inherent ability to direct selective 
binding to cell types or states and, therefore, confer “smartness” to NPs. These targeting 
ligands fall into several general classes: small molecules, polypeptide-based peptides, 
protein domains, antibodies, and nucleic acid-based aptamers. During my PhD I produced 
a novel functionalization of potential nano-delivery systems using chemokines and I 
evaluated their cell targeting performances. To achieve this challenging goal, the 
chemokine CXCL5 has been chosen as model protein to be adsorbed or covalently bound 
onto fluorescently labelled SiO2 NPs to precisely targeting CXCR2+ immune cells like 
THP-1 cell lines used as monocyte cell model. I demonstrated CXCR2+ cell preferential 
targeting by comparing particle uptake in THP-1 vs. low-CXCR2 expressing HeLa cells. 
In particular the covalent coupling of CXCL5 shows an advantage in cellular uptake 
compared with the adsorbed method due to the right disposition of the chemokine on NP 
surface that avoid aggregation phenomena. My results provide the proof of principle that 
chemokine decorated NMs enhance uptake through the fast chemokine-receptor binding 
allowing precise cell subset localization. The possibility to aim at selective chemokine 
receptor-expressing cells can be beneficial for the different pathological conditions 








Effect of PtNPs on undifferentiated and differentiated HL60 
1. Introduction 
The strong antioxidant activity exhibited by some nanoparticles is considered a new tool 
to develop novel therapies. Pt NPs have been poorly explored in nanomedicine, despite 
their well-known catalytic and antioxidant properties.  Different studies aimed at improve 
their catalytic properties by synthesizing PtNPs with different shape. In particular, the 
surface structure is important for determining and controlling the electrocatalytic 
properties of the material [145]. It is known that PtNPs could play an important role in 
nanomedicine because of their catalytic activity and ROS scavenging ability. Citrate-
capped Pt NPs of two sizes (5 and 20 nm) are endowed with strong catalase-, peroxidase, 
and superoxide dismutase-like activities. They are cytocompatible and can counteract 
molecular dysfunctions that cause the accumulation of intracellular ROS, suggesting 





Sources of ROS and key ROS molecules in signaling. ROS generation is a cascade of 




However, metallic NPs have often create interest about their potential toxicity, mostly 
induced by the loss of toxic ions, the presence of synthesis by products or the use of 
unsafe coating materials [147]. NP coatings have an important role for the potential 
immunotoxicity of the NPs, since they can directly bind to immune receptors or adsorb 
active molecules that change the immunological identity of the particles [148][89]. My 
group recently synthesized citrate-coated PtNPs demonstrating efficient intracellular 
ROS scavenging activity and a high degree of cytocompatibility [149]. The particle 
physicochemical properties like surface chemistry, size and shape regulate their 
biological fate and eventually the potential toxicity. All these parameters influence the 
NP delivery and its toxicological profile, often produces unexpected immune reactions. 
Immunity is characterized by innate and acquired defense systems that allow protection 
against pathogenic hazards [150]. Several active molecules and fast-responding 
leukocytes belong to the innate immune system, such as neutrophils, NK cells and 
monocyte/macrophage phagocytes. In particular, monocytes circulating in the 
bloodstream react to chemo-attractant inflammatory stimuli by migrating to the site of 
infection, where they differentiate into tissue-specific macrophages able to phagocyte and 
eliminate the threats. The response of the immune system to PtNPs is poorly investigated 
and part of my PhD thesis is aimed at studying the nano-bio-interactions between PtNPs 
and the immune cell line HL60 (Human promyelocytic leukemia cells). The HL60 cell 
line was established in 1977 from a patient with acute myeloid leukemia. The cells largely 
resemble promyelocytes but can be induced to differentiate terminally in vitro. Some 
reagents cause HL60 cells to differentiate into granulocyte-like cells, others to 
monocyte/macrophage-like cells. Compounds such as dimethyl sulphoxide (DMSO), and 
other compounds as diverse as retinoic acid and actinomycin D, all induce differentiation 
to granulocytes, while 1,25-dihydroxyvitamin D3, phorbol esters and sodium butyrate 
induce monocyte/macrophage differentiation [151]. The course of the differentiation 
induced by any of these agents is accompanied by a large number of changes in the cells 
[152] and is easily monitored by morphological, histochemical and immunological 
criteria. Thus, incubation with DMSO or retinoic acid leads, over a period of 5 days, to a 
progressive decrease in the size of HL60 cells and condensation of nuclear material with 
the appearance of kidney-shaped nuclei characteristic of the myelocyte and, later, lobed 
nuclei characteristic of banded and segmented neutrophils. 
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In particular I evaluated the potential interference of PtNPs with human HL60 
undifferentiated and differentiated cells, demonstrating that citrate-coated PtNPs are not 
toxic and cytocompatible  for these immune cells. 
2. Results 
2.1 Interaction of PtNPs with Undifferentiated and Differentiated HL60 
In vitro neutrophil-like granulocyte differentiation was obtained by administration of 
retinoic acid for 9 days. Fully differentiated non-adherent HL60 was investigated by flow 
cytometry. The results show higher values of side SSC and lower values of forward FSC, 
as reported in Figure 2. The increase of SSC agrees with the higher number of granules 
in the neutrophil-like phenotype, whereas lower FSC describes the smaller size of the 
differentiated cells. I considered differentiation of HL60 to be complete when >95% of 
cells were gating within arbitrarily fixed parameters of SSC and FSC corresponding to 
granulocyte morphology analysis by TEM.  
To evaluate the potential cytotoxicity of PtNPs in both non-adherent HL60 phenotypes, 
an AnnV/PI assay was performed by flow cytometry (Fig.3). I measured the number of 
necrotic/PI-positive cells and apoptotic/AnnV-positive cells, in particular 25nm, 100 
µg/mL PtNPs were added to the cell cultures for 6 h without inducing any significant 
















Flow cytometer dot plots and TEM images of internalized undifferentiated and 
differentiated HL60. Representation of the different cell FSC and SSC of HL60 and 
differentiated HL60 after 9 days of treatment with retinoic acid. TEM displays 
intracellular structures in HL60 and differentiated HL60 cells, showing morphological 













Dot plots show the comparison between untreated and PtNP-treated differentiated 













Evaluation of cells viability after the treatment with PtNPs evaluated by flow 
cytometry. (A,B) The bar graphs show the percentages of living undifferentiated (A) and 
differentiated (B) cells after 6 h incubation with 25, 50 and 100 µg/mL 5 nm-PtNPs. (C,D) 
AnnV/PI assay by flow cytometry. (C,D) Bars show necrosis (C) and apoptosis (D) of 
undifferentiated and differentiated HL60 cells, untreated or treated with PtNPs at different 
concentrations for 6 h. All the data represent the mean ± SD of three independent 
experiments [153]. 
 
2.2 PtNPs Internalization in Undifferentiated and Differentiated HL60 
TEM analysis of undifferentiated and differentiated HL60 cells treated with 5 nm citrate-
coated PtNPs was performed (Figure 4) to visualize the presence of NPs in cells and to 
evaluate their fate in cellular compartments. Low NP internalization in both non-adherent 
phenotypes was observed, although stimulation with retinoic acid induced a 







TEM images of undifferentiated and differentiated HL60 treated with 50 µg/mL of 
PtNPs. Magnification shows highlighted endocytotic vesicles retaining PtNPs[153]. 
 
3. Discussion  
The development of NPs as drug delivery system requires deep investigation of particle-
cell interactions, and their potential impairment of cell-cycle processes. Special attention 
must be given to the absence of immunogenicity and toxicity of NPs to avoid immune 
system reactions and to favor the application in several fields of medicine [154][155]. My 
group have already proposed PtNPs as novel catalytic nanomaterials for biomedical 
applications [149]. Their surface chemistry allows intracellular ROS scavenging and 
impairment of inflammatory pathways [156] suggesting PtNPs as antioxidant and anti-
inflammatory “nanoenzymes”. To extend the observation of PtNP effects on innate 
immune cells, human promyelocytic HL60 cells, are induced, using retinoic acid, to 
differentiate into granulocytes that express morphologic and functional features of mature 
neutrophils (Figure 2). Moreover, to evaluate NPs cytotoxicity on HL60 cells, was 
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performed the Annexin V/PI assay by flow cytometry-based methods. Propidium iodide 
(PI) is widely used in conjunction with Annexin V to determine if cells are viable, 
apoptotic, or necrotic through differences in plasma membrane integrity and permeability 
[157]. PI is used as nuclear stains because it is stable and a good indicator of cell viability, 
based on its capacity to exclude dye in living cells [158]. The ability of PI to enter a cell 
is dependent upon the permeability of the membrane; PI does not stain live or early 
apoptotic cells due to the presence of an intact plasma membrane. In late apoptotic and 
necrotic cells, the integrity of the plasma and nuclear membranes decreases, allowing PI 
to pass through the membranes, intercalate into nucleic acids, and display red 
fluorescence [159]. As reported in Figure 4, 5 nm citrate-coated PtNPs do not show 
toxicity in fact NPs do not induce necrosis or apoptosis in both HL60 phenotypes. 
Interestingly, PtNPs internalization in differentiated and undifferentiated cells is similarly 
low (Figure 5), indicating that it is not increased by the phagocytic phenotype. This may 
be due to the non-adherent nature of these cell lines, and the shorter time of PtNP 
exposure. I chose a 6 h treatment for HL60, because the fast proliferation time of 
undifferentiated cells [160] would have diluted the initial NP concentration-per-cell over 
24 h. Therefore, the results shows that PtNPs do not induce toxicity for HL60 cells, 
exhibiting low NP internalization ability. These results are in contrast with the work of 
Daniela Guarnieri et al. [161] in which PtNPs of different diameters (2,5 5 20 nm) are 
linked to the cell penetrating peptides (CPP) gH625, to escape the endo-lysosomal 
compartment and deliver NPs within the cytoplasm, as a function of the NP size. The 
uptake was evaluated on human cervix epithelioid carcinoma (HeLa) cells demonstrating 
a 4-fold increase for gHPt5 and gHPt20 NPs and a 12-fold increase for gHPt2.5 NPs with 
respect to pristine particles. These results suggest that the ability of gH625 peptide to 
enhance NP cellular uptake is strongly limited by the size of the NP cargo. In my project 
PtNps penetrate very low in THP-1 cells because they are cells in suspension, not adherent 
like HeLa cells, therefore it’s  more difficult for cells to come in contact with NPs. 
 
4. Materials and Methods 
4.1 Nanoparticles 
5 nm Citrate-capped PtNPs, synthesized and characterized as previously reported [162]. 
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4.2 Cell Culture 
HL60 cells (ATCC Manassas, VA, USA) were grown in RPMI-1640 (Thermo Fisher 
Scientific) supplemented with 10% FBS (Thermo Fisher Scientific), 1% Penicillin-
Streptomycin (Sigma-Aldrich) in a 5% CO2 humidified atmosphere at 37°C [153]. 
4.3 Differentiation Assay 
HL60 cells were incubated with 1 µM all-trans retinoic acid (ATRA) (Sigma-Aldrich, 
Saint Luis, MO, USA) for 9 days to obtain complete differentiation in neutrophil-like 
cells. Differentiation along the granulocytic pathway was monitored by characteristic 
changes in morphology using the flow cytometry with MACSQuant Analyzer (Miltenyi 
Biotec, Bergish, Germany) [153]. 
4.4 Transmission Electron Microscopy 
Suspension cells (HL60 and differentiated HL60) were incubated with 50 µg/mL PtNPs 
for the proper time, then washed twice with RPMI and fixed for 45 min in a fixative 
solution (2% Glutaraldehyde in complete culture medium). The samples were centrifuged 
and the pellet fixed again with 1.5% Glutaraldehyde solution in Na-Cacodylate buffer 0.1 
M. A final post-fixation (2 h) in 1% OsO4 solution in Na-Cacodylate buffer 0.1 M was 
performed. The fixed samples were stained overnight in a 1% Uranyl acetate aqueous 
solution at 4°C. Samples were washed in water and completely dehydrated with a scale 
of Ethanol, transferred in Propylene Oxide and finally infiltrated with epoxy Spurr™ 
(SPI-Chem, West Chester, PA, USA) resin. Once the resin had hardened for 48 h in oven 
at 65°C, thin sections were cut with a Leica EM UC6 ultra-microtome. TEM images were 
collected with a Jeol JEM 1011 (Jeol, Tokyo, Japan) electron microscope (Electron 
Microscopy Facility—Fondazione Istituto Italiano di Tecnologia, Genova, Italy), 
operating at an acceleration voltage of 100 kV, and recorded with an 11 Mp fiber optical 
charge-coupled device (CCD) camera (Gatan Orius SC-1000) [153]. 
4.5 Annexin-PI Assay 
Cell viability was quantified by using Annexin V-PI assay (Miltenyi Biotec, Bergish, 
Germany) according to the manufacturer’s instructions. In brief, HL60 and differentiated 
HL60 cells were incubated with 50 µg/mL PtNPs for 6 h. After the treatments, the cells 
were washed and incubated with Annexin V-FITC for 15 min in the dark at room 
temperature. Subsequently, the cells were washed and  propidium iodide (PI) solution 
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was added immediately prior to analysis by flow cytometry with MACSQuant Analyzer. 
The percentage of necrotic or apoptotic cells was evaluated using MACSQuantify 
software [153]. 
4.6 Flow Cytometry 
For the evaluation of cell viability, HL60 and differentiated HL60 cells were incubated 
with 50 µg/mL of 5 nm PtNPs. After 6 h incubation, the effect of PtNP internalization on 
cell viability was evaluated by flow cytometry with MACSQuant Analyzer (Miltenyi 
Biotec, Bergish, Germany) using MACSQuantify software [153]. 
 
5. Conclusions 
In this project, I evaluated PtNPs effects on innate immune cells, in particular I exploited 
undifferentiated human HL60 cells, and differentiated them into a neutrophil-like 
phenotype to demonstrate that cells viability is not affected by the treatment with PtNPs. 
The particles internalized within these cells seem very few, emphasizing the specificity 
of PtNPs-immune cell type interaction. All these results highlight the influence PtNPs 
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